✦ LIBER ✦

Concomitant use of proton pump inhibitors and metabolically competing drugs, and the risk of drug-drug interaction induced adverse events

✍ Scribed by McLaughlin, Trent P.; Yazdani, Cyrus; Okamoto, Lynn J.; Tedeschi, Michael

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the Clopidogrel–Proton Pump In

✍ Sharvari M. Bhurke; Bradley C. Martin; Chenghui Li; Amy M. Franks; Zoran Bursac; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Inconsistencies surrounding the risk of

✍ Kwok, Chun Shing; Loke, Yoon Kong 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 289 KB

Lack of a clinically significant drug-dr

✍ de Kanter, C. T. M. M.; Colbers, A. P. H.; Blonk, M. I.; Verweij-van Wissen, C. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 325 KB

Risk of adverse events with concomitant

✍ Alawi A. Alsheikh-Ali; Heather M. Abourjaily; Richard H. Karas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 58 KB

PCV1 Evaluation of Statin-Associated Adv

✍ Wang, M.T.; Chiang, P.Y.; Lee, W.J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

T1078 Risk of Adverse Cardiovascular Eve

✍ Ngamruengphong, Saowanee; Leontiadis, Grigorios I.; Crowell, Michael D.; Chaliki 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB